HSP70 knockdown and CTL depletion blocked the antitumor effect of Amuc_2172*, suggesting that Amuc_2172* inhibits tumorgenesis by inducing HSP70 secretion and CTL immune activity
No serious organ toxicity has been documented in rodent models
Si no respondes en 6 meses, considera baln gstrico o manga
May trend downward with healing but also affected by other health factors
Concerning reactions that warrant medical review: Progressive swelling increasing size of a lump or swelling over 2448 hours Persistent redness redness that spreads beyond the immediate injection site or intensifies rather than fading Warmth and pain the injection site feels hot to touch and becomes increasingly painful, suggesting possible infection (cellulitis) Systemic symptoms fever, chills, or feeling generally unwell following an injection Allergic-type reactions hives, itching, or rash developing at or beyond the injection site Severe, persistent abdominal pain especially if radiating to the back, with or without vomiting (possible pancreatitis) Jaundice yellowing of the skin or eyes, which could indicate gallbladder problems (a known risk with Saxenda) It is important to note that there is no official link between Saxenda and increased bleeding disorders or coagulopathy